SPYRAL DYSTAL Study to Evaluate the Effects of RDN Using Fewer, Targeted Ablations to Achieve Meaningful Blood Pressure Reductions DUBLIN, Feb. 04, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced it will begin enrollment in a pilot study evaluating the safety and efficacy of the Symplicity™ Spyral renal denervation (RDN) system […]
Peripheral/Endo
Data Presented at ISET Shows Impressive Revascularization in Chronic Total Occlusions with FLEX Vessel PrepTM System
Minneapolis, MN, January 30, 2020 – VentureMed Group, Inc., a privately-held medical device innovator focused on vessel preparation for interventional treatment of peripheral arterial disease (PAD) and stenoses of arteriovenous (AV) fistulas and grafts, announced data presented at the International Symposium on Intervascular Therapy (ISET) Annual Conference, Jan. 22-24, in […]
biolitec® – New ELVeS® Radial® 2ring Pro laser fiber for severely tortuous veins
New laser fiber ELVeS® Radial® 2ring Pro with its own canal for saline solution – Stretching of severely tortuous veins – Optimal removal of residual blood in large-volume veins – Avoidance of additional punctures in complex vein structures – Radial fiber from biolitec® has set the standard for over 10 […]
Vascular Therapies Completes Upsized $17.3 Million Private Financing
– Company funded through 2020. Topline Phase 3 results for Sirogen expected to be announced in Q2 2020 – CRESSKILL, N.J, January 28, 2020 – Vascular Therapies, a clinical-stage biopharma company focused on improving vascular access outcomes in patients with kidney disease, today announced the closing of an upsized $17.3 […]
MedAlliance Receives CE Mark Approval for SELUTION SLR™ Sirolimus Drug Eluting Balloon for Endovascular Applications
3 February 2020 – MedAlliance has announced the award of its first CE Mark approval: for SELUTION SLR™, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of peripheral arterial disease. This approval applies to sizes from 2.0 x 20mm to 7.0 x 150mm. This award was supported by two-year […]
Intact Vascular Expands Tack Endovascular System® Portfolio Offering
New Larger Implant Enables Focal Dissection Repair Across a Wider Range of Vessel Sizes WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced Food and Drug Administration PMA approval for the expansion of its Tack Endovascular System® (6F) portfolio. The new approved device […]
JanOne Scientific Advisory Board Chair and Leading Pain Expert Featured on ABC-7 WJLA America This Week
Dr. Christopher Kevil, pioneer in nitrite based PAD treatment and Dr. Amol Soin, foremost expert is neuropathic pain, provide scientific insight on the pain relieving qualities of JanOne’s lead drug candidate Interview to be distributed nationally on all 193 Sinclair broadcasting network affiliate stations in 89 markets across the nation […]
Ra Medical Systems Receives FDA IDE Approval to Begin Pivotal Atherectomy Clinical Study
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces approval from the U.S. Food and Drug Administration (FDA) that the Company has provided sufficient data to support initiating an investigational device exemption (IDE) to […]
Leading Cardiovascular Researcher And PAD Treatment Pioneer, Dr. Christopher Kevil, To Chair JanOne Scientific Advisory Board
Kevil brings global scientific expertise to advance JanOne’s drug development portfolio and advise on upcoming Phase 2b clinical trials for PAD LAS VEGAS, Jan. 16, 2020 /PRNewswire/ — JanOne Inc. (NASDAQ:JAN) appoints Christopher Kevil, Ph.D., a pioneer in nitrite based PAD treatment, to lead its scientific advisory board. In this role, Dr. Kevil will […]
Emboline Completes Enrollment in SafePass 2 Clinical Study of Emboliner Embolic Protection Catheter
Early Results from First 24 Patients Show Excellent Safety Profile and Technical Performance, with Significant Debris Capture and Removal in All Patients SANTA CRUZ, Calif.–(BUSINESS WIRE)–Emboline™, Inc., developer of total embolic protection technology for transcatheter aortic valve replacement (TAVR), today announced completion of enrollment in its SafePass™ 2 clinical study […]
Recent
Medera Expands Scientific Advisory Board with Leading Heart Failure and Cardiopulmonary Physiology Experts to Advance HFpEF Gene Therapy Program
BioCardia Announces $4.4 Million Financing
InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures
Popular
- No commented posts yet